Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
152.43
-2.15 (-1.39%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ascendis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 9,122 | 8,234 | 7,125 | 6,824 | 7,635 | 9,007 | |
| Market Cap Growth | 15.56% | 15.56% | 4.41% | -10.63% | -15.23% | 35.62% | |
| Enterprise Value | 9,430 | 8,416 | 7,347 | 6,449 | 6,676 | 7,922 | |
| Last Close Price | 152.43 | 137.67 | 125.95 | 122.13 | 134.53 | 166.78 | |
| PS Ratio | 23.44 | 21.87 | 24.17 | 124.77 | 863.17 | 1059.02 | |
| PB Ratio | -83.35 | -75.24 | -44.24 | 24.25 | 7.60 | 8.78 | |
| P/TBV Ratio | - | - | - | 24.70 | 7.64 | 8.84 | |
| EV/Sales Ratio | 25.05 | 22.35 | 24.92 | 117.92 | 754.73 | 931.41 | |
| Debt / Equity Ratio | -8.10 | -8.10 | -4.42 | 1.93 | 0.12 | 0.11 | |
| Asset Turnover | 0.36 | 0.36 | 0.28 | 0.05 | 0.01 | 0.01 | |
| Inventory Turnover | 0.18 | 0.18 | 0.26 | 0.12 | - | - | |
| Quick Ratio | 0.81 | 0.81 | 0.62 | 1.06 | 7.03 | 13.75 | |
| Current Ratio | 1.17 | 1.17 | 0.95 | 1.29 | 8.03 | 14.02 | |
| Return on Equity (ROE) | - | - | -818.43% | -101.69% | -44.54% | -58.36% | |
| Return on Assets (ROA) | -17.38% | -17.38% | -29.73% | -32.29% | -27.35% | -24.95% | |
| Return on Capital (ROIC) | -27.89% | -27.89% | -44.83% | -39.89% | -29.42% | -26.42% | |
| Earnings Yield | -4.29% | -4.75% | -7.47% | -9.13% | -5.71% | -5.69% | |
| FCF Yield | -3.53% | -3.87% | -7.29% | -7.99% | -6.57% | -3.96% | |
| Buyback Yield / Dilution | -2.85% | -2.85% | -0.38% | -2.37% | -8.21% | -8.84% | |
| Total Shareholder Return | -2.85% | -2.85% | -0.38% | -2.37% | -8.21% | -8.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.